Skip to content
healthcare.dev

Liothyronine Sodium

NDC 42794-020, Liothyronine Sodium, tablet, from SIGMAPHARM LABORATORIES, LLC.

Product NDC
42794-020
Status
Listed
Labeler
SIGMAPHARM LABORATORIES, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA200295
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42794-020 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIOTHYRONINE SODIUM50 ug/1

Pharmacologic classes

Triiodothyronine [CS]; l-Triiodothyronine [EPC]

Package NDCNDC-11Package
42794-020-0242794002002100 TABLET in 1 BOTTLE (42794-020-02)
42794-020-124279400201290 TABLET in 1 BOTTLE (42794-020-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/38ef3766-bb9a-402e-9e4a-ad8bb5b26e4c
  • NADAC price for package 42794002002

    GET /v1/drugs/nadac/42794002002
  • NADAC price for package 42794002012

    GET /v1/drugs/nadac/42794002012

Use it

Look up 42794-020 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42794-020 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42794-020. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.